This contract opportunity involves establishing a non-exclusive discount agreement for medications containing the active ingredient Teriparatide (ATC Code: H05AA02). The contract will be effective from December 1, 2025, to November 30, 2027, with the option for suppliers to enter into the contract a
387 days left to bid. Opened 11 months ago, deadline 27 Sept 2027.
This contract opportunity involves establishing a non-exclusive discount agreement for the medication Omalizumab (ATC Code: R03DX05) in Germany. The contract will be effective from December 1, 2024, to November 30, 2026, with the option for suppliers to enter into the contract at any time during thi
This contract opportunity involves the establishment of non-exclusive discount agreements for the drug Trastuzumab, classified under ATC code L01FD01, in the regions of Lower Saxony, Bremen, and Saxony-Anhalt. The focus is on parenteral preparations made from finished medicinal products for oncology
Apply for up to £500,000 to establish the Medicines Manufacturing Data Institute, a trusted data hub for the medicines ecosystem, with potential for up to £5 million phase 2 funding.
UHN seeks a consultant-led ENT service provider to manage comprehensive patient pathways, improve access, and ensure RTT compliance.
A track and trace system to manage sterile instrument and equipment movement throughout the sterilization and distribution process in hospital central sterile services departments.
Leicester City Council is seeking provider input through a Soft Market Test to inform future commissioning of inpatient detoxification services for people using drugs and alcohol.
